View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Wedbush Research
  • Wedbush Research
W WAYFAIR INC.
XNCR XENCOR INC.
WDC WESTERN DIGITAL CORPORATION
TRIP TRIPADVISOR INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MELI MERCADOLIBRE INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
EXPE EXPEDIA GROUP INC.
ETSY ETSY INC.
EBAY EBAY INC.
AXTI AXT INC.
NFLX NETFLIX INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
CCRN CROSS COUNTRY HEALTHCARE INC.
PTGX PROTAGONIST THERAPEUTICS
CVNA CARVANA CO. CLASS A
ISR ISORAY
SE SEA ADS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
BKNG BOOKING HOLDINGS INC.
RCUS ARCUS BIOSCIENCES
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
LYFT LYFT
PINS PINTEREST INC. CLASS A
UBER UBER TECHNOLOGIES INC.
GOSS GOSSAMER BIO
CHWY CHEWY INC. CLASS A
SMCI SUPER MICRO COMPUTER
IDYA INC.
RVMD IDEAYA BIOSCIENCES
ORIC REVOLUTION MEDICINES
ZNTL ORIC PHARMACEUTICALS
COGT ZENTALIS PHARMACEUTICALS
DASH COGENT BIOSCIENCES INC
ABNB DOORDASH
NUVB AIRBNB INC. CLASS A
RBLX NUVATION BIO INC (A)
CGEM ROBLOX
FHTX CULLINAN ONCOLOGY INC
STX FOGHORN THERAPEUTICS
GLUE SEAGATE TECHNOLOGY HLDGS PLC
GFS MONTE ROSA THERAPEUTICS INC
NUVL GLOBALFOUNDRIES INC
CART NUVALENT INC
TLX MAPLEBEAR INC.
BBOT TELIX PHARMACEUTICALS LIMITED
EIKN BRIDGEBIO ONCOLOGY THERAPEUTICS INC
EIKON THERAPEUTICS INC
Michael Piccolo
  • Michael Piccolo

Daily Recap: KMX, IBM, FUN, UL, JHG/VCTR, DIS, LULU, 9104, OSUR, PERF,...

International Business Machines Corp. (IBM - $256.11)News Reports CEO Sees More AI Deals in Friendlier Regulatory Climate.According to Bloomberg, IBM's CEO Arvind Krishna signaled on March 17, 2026, that the company intends to continue pursuing M&A in AI and hybrid cloud, citing a materially mo

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

4Q25 Postmortem: Evaluating AI Risk in the Current Landscape

In this report, we establish an initial framework to assess exposure to AI-enabled risk across our coverage group. Specifically, we evaluate the risk of replacement, disintermediation, or both. Our framework measures structural defensibility and business model differentiation against the difficulty

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

600K Unit Margin Tune-Up; Outperform, $425 PT

Carvana reported strong revenue and unit growth, while GPU and adj. EBITDA were below expectations for 4Q. The company reported 4Q revenue of $5.6B (+58.0% Y/Y), ~7% ahead of St. expectations. While adj. EBITDA in the quarter was the highest quarterly amount the company has reported to date, totali

Carvana Co: 1 director

A director at Carvana Co sold 1,047 shares at 398.540USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

Tough Road Ahead; Neutral, $36 PT

Figure 1. 3QFY26 Results vs. EstimatesSource: Company reports, Wedbush estimates, FactSet consensusCarMax reported results mostly in-line with lowered expectations for 3Q. In the quarter, the company reported revenue of $5.8B (-6.9% Y/Y), ~3% ahead of St. expectations of $5.6B (-9.9% Y/Y). 3Q retai

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt
Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

3Q25 Postmortem: Sentiment Guide Following Results

Post-results, we think the disconnect between fundamentals and investor sentiment offers attractive upside for the highest-quality names in our coverage. We’ve become more constructive on the companies below:META (Outperform) - We are adding Meta Platforms to the Best Ideas List and maintain our $9

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

Wheels Falling Off, Good Bones; Neutral, $40 PT

Figure 2. 3QFY26 Estimate RevisionsSource: Company reports, Wedbush estimates, FactSet consensusFigure 3. FY26 Estimate RevisionsSource: Company reports, Wedbush estimates, FactSet consensus

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

Donate Your Market Share Here; Neutral, $380 PT

3Q25 results were above consensus. Carvana reported strong revenue growth to $5.6B (+54.5% Y/Y), ~11% ahead of St. expectations. Adj. EBITDA of $637mm (11.3% margin) exceeded consensus by ~$35mm, reporting the highest level of adj. EBITDA in company history. GPU of $7,503 only decreased by -2.4% Y/

Carvana Co.: Update to credit analysis following upgrade of CFR to B2 ...

Carvana's credit profile reflects improved operating performance, higher unit sales and gross profit per vehicle as well as a large gain on sale of receivables and costs controls initiative.

Moody's Ratings upgrades Carvana's CFR to B2, outlook remains positive

Moody's Ratings (Moody's) upgraded Carvana Co.'s ("Carvana") corporate family rating (CFR) to B2 from B3 and probability of default rating (PDR) to B2-PD from B3-PD. The company's senior secured global notes ratings were upgraded to B2 from B3 and senior unsecured global notes ratings were upgraded ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch